US Edition
News from ajmc.com
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top ajmc.com News
Medicare · United StatesDrugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers, the Trump administration said Tuesday.See the Story
Trump administration announces 15 new drugs for Medicare price negotiation program
76% Center coverage: 81 sources
US Politics · United StatesThe U.S. has proposed an average rate increase of 0.09% in payments to private insurers next year for the Medicare Advantage plans they manage, the government said on Monday, driving shares of the companies down more than 10%.See the Story
US proposes slight rise in 2027 Medicare insurer payments, shares fall
67% Center coverage: 15 sources
United States · United States/PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and...See the Story
DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible
42% Center coverage: 7 sources
